The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gowda, S. D.
Right arrow Articles by Engleman, E. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gowda, S. D.
Right arrow Articles by Engleman, E. G.

The Journal of Immunology, Vol 142, Issue 3 773-780, Copyright © 1989 by American Association of Immunologists


ARTICLES

Evidence that T cell activation is required for HIV-1 entry in CD4+ lymphocytes

SD Gowda, BS Stein, N Mohagheghpour, CJ Benike and EG Engleman
Department of Pathology, Stanford University School of Medicine, CA 94305.

The relationship of T cell activation to HIV entry and generation of viral DNA intermediates was studied in freshly isolated CD4+ T lymphocytes. Unstimulated cells exposed to infectious virus for up to 48 h did not synthesize any detectable unintegrated HIV DNA duplex forms or integrated genomic provirus. However, activation of these cells with either PHA or OKT3 (anti-CD3) mAb before viral exposure resulted in the generation of unintegrated HIV DNA after 6 h and integrated copies after 24 h. Cell-to-cell fusion studies showed significantly attenuated fusion between freshly isolated resting T cells and T cells constitutively expressing high levels of HIV envelope glycoprotein (HXB/gpt) compared with T cells first stimulated with either PHA or OKT3 mAb. The baseline fusion observed with resting T cells is believed to be a consequence of allogeneic stimulation by the HXB/gpt cell line. These results provide evidence that HIV entry and HIV envelope-dependent cell-to-cell fusion require T cell activation.


This article has been cited by other articles:


Home page
J. Leukoc. Biol.Home page
M. Zaitseva, T. Romantseva, J. Manischewitz, J. Wang, D. Goucher, and H. Golding
Increased CXCR4-dependent HIV-1 fusion in activated T cells: role of CD4/CXCR4 association
J. Leukoc. Biol., December 1, 2005; 78(6): 1306 - 1317.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
A. Joshi, H. Garg, M. B. Tompkins, and W. A. Tompkins
Preferential Feline Immunodeficiency Virus (FIV) Infection of CD4+ CD25+ T-Regulatory Cells Correlates both with Surface Expression of CXCR4 and Activation of FIV Long Terminal Repeat Binding Cellular Transcriptional Factors
J. Virol., April 15, 2005; 79(8): 4965 - 4976.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
T. N. Q. Pham, S. A. MacParland, C. S. Coffin, S. S. Lee, F. R. Bursey, and T. I. Michalak
Mitogen-induced upregulation of hepatitis C virus expression in human lymphoid cells
J. Gen. Virol., March 1, 2005; 86(3): 657 - 666.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
L. Fong, M. Mengozzi, N. W. Abbey, B. G. Herndier, and E. G. Engleman
Productive Infection of Plasmacytoid Dendritic Cells with Human Immunodeficiency Virus Type 1 Is Triggered by CD40 Ligation
J. Virol., October 2, 2002; 76(21): 11033 - 11041.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
T. Pierson, T. L. Hoffman, J. Blankson, D. Finzi, K. Chadwick, J. B. Margolick, C. Buck, J. D. Siliciano, R. W. Doms, and R. F. Siliciano
Characterization of Chemokine Receptor Utilization of Viruses in the Latent Reservoir for Human Immunodeficiency Virus Type 1
J. Virol., September 1, 2000; 74(17): 7824 - 7833.
[Abstract] [Full Text]


Home page
Obstet GynecolHome page
A. D. BARDEGUEZ, E. CONNOR, R. STEPHENS, T. N. DENNY, B. HOLLAND, and J. OLESKE
Effect of Human Immunodeficiency Virus Infection on Serum Beta2-Microglobulin Levels in Pregnant Women
Obstet. Gynecol., October 1, 1999; 94(4): 537 - 542.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
J. L. Riley, K. Schlienger, P. J. Blair, B. Carreno, N. Craighead, D. Kim, R. G. Carroll, and C. H. June
Modulation of Susceptibility to HIV-1 Infection by the Cytotoxic T Lymphocyte Antigen 4 Costimulatory Molecule
J. Exp. Med., June 6, 1999; 191(11): 1987 - 1998.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. Kulkosky, A. Laptev, S. Shetty, A. Srinivasan, M. BouHamdan, D. J. Prockop, and R. J. Pomerantz
Human Immunodeficiency Virus Type 1 Vpr Alters Bone Marrow Cell Function
Blood, March 15, 1999; 93(6): 1906 - 1915.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
E. Barker, K. N. Bossart, and J. A. Levy
Differential Effects of CD28 Costimulation on HIV Production by CD4+ Cells
J. Immunol., December 1, 1998; 161(11): 6223 - 6227.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
L. Huang, I. Bosch, W. Hofmann, J. Sodroski, and A. B. Pardee
Tat Protein Induces Human Immunodeficiency Virus Type 1 (HIV-1) Coreceptors and Promotes Infection with both Macrophage-Tropic and T-Lymphotropic HIV-1 Strains
J. Virol., November 1, 1998; 72(11): 8952 - 8960.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. F. Chuang, K. F. Killam Jr., and R. Y. Chuang
Induction and Activation of Mitogen-activated Protein Kinases of Human Lymphocytes as One of the Signaling Pathways of the Immunomodulatory Effects of Morphine Sulfate
J. Biol. Chem., October 24, 1997; 272(43): 26815 - 26817.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. C. Bleul, L. Wu, J. A. Hoxie, T. A. Springer, and C. R. Mackay
The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes
PNAS, March 4, 1997; 94(5): 1925 - 1930.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C.-S. Chou, O. Ramilo, and E. S. Vitetta
Highly purified CD25- resting T cells cannot be infected de novo with HIV-1
PNAS, February 18, 1997; 94(4): 1361 - 1365.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Chirmule, H. Goonewardena, S. Pahwa, R. Pasieka, V. S. Kalyanaraman, and S. Pahwa
HIV-1 Envelope Glycoproteins Induce Activation of Activated Protein-1 in CD4+ T Cells
J. Biol. Chem., August 18, 1995; 270(33): 19364 - 19369.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
C Callebaut, B Krust, E Jacotot, and A. Hovanessian
T cell activation antigen, CD26, as a cofactor for entry of HIV in CD4+ cells
Science, December 24, 1993; 262(5142): 2045 - 2050.
[Abstract] [PDF]


Home page
ScienceHome page
R. Finberg, S. Wahl, J. Allen, G Soman, T. Strom, Murphy JR, and J. Nichols
Selective elimination of HIV-1-infected cells with an interleukin-2 receptor-specific cytotoxin
Science, June 21, 1991; 252(5013): 1703 - 1705.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
P. Chen, E. Flory, A. Avots, B. W. M. Jordan, F. Kirchhoff, S. Ludwig, and U. R. Rapp
Transactivation of Naturally Occurring HIV-1 Long Terminal Repeats by the JNK Signaling Pathway. THE MOST FREQUENT NATURALLY OCCURRING LENGTH POLYMORPHISM SEQUENCE INTRODUCES A NOVEL BINDING SITE FOR AP-1 FACTORS
J. Biol. Chem., June 30, 2000; 275(27): 20382 - 20390.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1989 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1989 by The American Association of Immunologists, Inc. All rights reserved.